Axsome Therapeutics (AXSM) Cash flow

2,347 Followers

Axsome Therapeutics Cash Flow

AXSM's free cash flow for Q4 2025 was $-18.72M. For the 2025 fiscal year, AXSM's free cash flow was decreased by $34.80M and operating cash flow was $-18.65M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -93.41M	$ -128.41M	$ -145.08M	$ -116.51M	$ -108.23M
Investing Cash Flow	$ -480.00K	$ -270.00K	$ -582.00K	$ -53.70M	$ -308.00K
Financing Cash Flow	$ 101.47M	$ 57.84M	$ 331.01M	$ 284.58M	$ 11.13M
End Cash Position	$ 322.93M	$ 315.35M	$ 386.19M	$ 200.84M	$ 86.47M
Free Cash Flow	$ -93.89M	$ -128.68M	$ -145.66M	$ -117.21M	$ -108.53M

Currency in USD